The petition of the day is:
Issue: Whether the mere filing of an abbreviated new drug application by a generic pharmaceutical manufacturer is sufficient to subject the manufacturer to specific personal jurisdiction in any state where it might someday market the drug.
CLICK HERE FOR FULL VERSION OF THIS STORY